A clinical trial to study the effect of two different routes (nasal and parenteral) of administration of a drugs, vitamin B12, in patients with macrocytic anemia
Phase 3
- Conditions
- Health Condition 1: D519- Vitamin B12 deficiency anemia, unspecified
- Registration Number
- CTRI/2023/09/058162
- Lead Sponsor
- Command Hospital Central Command
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Hemoglobin < 13g/dL male, <12g/dL female.
2.Mean corpuscular volume >100 fL.
3.Normal Transferrin saturation.
4.Should not have any comorbidities causing anemia.
Exclusion Criteria
Patients with macrocytic anemia having any of the following characteristics will be excluded
1.Patients receiving other modalities of treatment and/or alternative medicine.
2.Patients who did not consent for the study.
3.Rhinitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method